The aim is to prevent fraud, but analysis by the BIA shows the measure will have unintended consequences for life science companies.Original Article
You may also like
About the author
David Miller
a pharmacist, a tech enthusiastic, who explored the Internet to gather all latest information pharma, biotech, healthcare and other related industries.